spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  baroreceptors 

 HSMN NewsFeed - 6 Jan 2016
Vascular Dynamics’ MobiusHD(TM) System Receives CE Mark for the Treatment of Resistant Hypertension
Devices Cardiology Regulatory
 HSMN NewsFeed - 17 Mar 2015
CVRx(R) Barostim Therapy(TM) for Heart Failure Clinical Trial Results Presented in a Featured Clinical Research Session of the American College of Cardiology Annual Conference
Devices Cardiology
 HSMN NewsFeed - 8 Jan 2015
Vascular Dynamics Inc. Secures $16.85 Million Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 16 Dec 2014
CVRx(R) Granted Humanitarian Device Exemption Approval from FDA for Barostim neo legacy(TM) Hypertension Therapy Device
Devices Cardiology FDA
 HSMN NewsFeed - 11 Dec 2014
CVRx(R) Granted CE Marking of the Barostim neo System(TM) for Conditional MRI Compatibility
Devices Cardiology Regulatory
 HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Devices Cardiology
 HSMN NewsFeed - 5 Nov 2013
CVRx(R) & DaVita Announce Strategic Partnership
Devices
 HSMN NewsFeed - 30 Oct 2013
CVRx Closes $12 Million Additional Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 9 Jul 2012
CVRx(R) Names Philippe Wanstok Chief Commercial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 7 Nov 2011
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
Devices Personnel
 HSMN NewsFeed - 25 Aug 2011
CVRx(R) Receives CE Mark Approval and Introduces New Implantable Device for Hypertension, the Barostim neo(TM)
Devices Cardiology Regulatory
 HSMN NewsFeed - 21 Jun 2010
Four-Year Clinical Study Findings Show Significant and Persistent Reduction in Blood Pressure with Rheos(R) System
Devices
 HSMN NewsFeed - 30 Mar 2009
Longer-Term Clinical Trial Findings Show Significant Reduction in Blood Pressure, Improvement in Heart Function with CVRx Rheos System
Devices Cardiology
 HSMN NewsFeed - 23 Sep 2008
Clinical Data Show CVRx(R) Rheos(R) Therapy Improved Heart Structure and Function in Early-Stage Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 30 Jul 2008
CVRx(R), Inc. Closes $84 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 18 Jun 2008
Two-Year Clinical Trial Findings Show Significant and Persistent Reduction in Blood Pressure with CVRx(R) Rheos(R) Hypertension Therapy
Devices
 HSMN NewsFeed - 28 Apr 2008
New Implantable Device Designed to Lower High Blood Pressure May Offer Hope for Millions of Patients
Devices Cardiology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.